GB2493955A - Methods and compositions for reducing allergic reactions to fragranced products and perfumes - Google Patents
Methods and compositions for reducing allergic reactions to fragranced products and perfumes Download PDFInfo
- Publication number
- GB2493955A GB2493955A GB1114692.5A GB201114692A GB2493955A GB 2493955 A GB2493955 A GB 2493955A GB 201114692 A GB201114692 A GB 201114692A GB 2493955 A GB2493955 A GB 2493955A
- Authority
- GB
- United Kingdom
- Prior art keywords
- text
- vitamin
- oxidation
- skin
- reducing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000002304 perfume Substances 0.000 title claims abstract description 25
- 206010020751 Hypersensitivity Diseases 0.000 title claims abstract description 23
- 239000000203 mixture Substances 0.000 title claims abstract description 22
- 238000000034 method Methods 0.000 title claims abstract description 20
- 230000003647 oxidation Effects 0.000 claims abstract description 40
- 238000007254 oxidation reaction Methods 0.000 claims abstract description 40
- 239000000126 substance Substances 0.000 claims abstract description 37
- 206010012442 Dermatitis contact Diseases 0.000 claims abstract description 25
- 208000026935 allergic disease Diseases 0.000 claims abstract description 16
- 230000007815 allergy Effects 0.000 claims abstract description 15
- 208000002029 allergic contact dermatitis Diseases 0.000 claims abstract description 12
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 11
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 8
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 8
- 235000006708 antioxidants Nutrition 0.000 claims abstract description 8
- 230000006698 induction Effects 0.000 claims abstract description 8
- 230000002401 inhibitory effect Effects 0.000 claims abstract description 7
- 239000004322 Butylated hydroxytoluene Substances 0.000 claims abstract description 6
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 claims abstract description 6
- 235000010354 butylated hydroxytoluene Nutrition 0.000 claims abstract description 6
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims abstract description 5
- 229940095259 butylated hydroxytoluene Drugs 0.000 claims abstract description 5
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 claims abstract description 5
- 229940042585 tocopherol acetate Drugs 0.000 claims abstract description 5
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 4
- OFUHPGMOWVHNPN-QWZFGMNQSA-N [(2r)-2,5,7,8-tetramethyl-2-[(4r,8r)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl] (9z,12z)-octadeca-9,12-dienoate Chemical compound O1[C@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CCC2=C(C)C(OC(=O)CCCCCCC\C=C/C\C=C/CCCCC)=C(C)C(C)=C21 OFUHPGMOWVHNPN-QWZFGMNQSA-N 0.000 claims abstract description 4
- 235000019282 butylated hydroxyanisole Nutrition 0.000 claims abstract description 4
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 4
- 230000004044 response Effects 0.000 claims abstract description 4
- 229940046009 vitamin E Drugs 0.000 claims abstract description 4
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 4
- 239000011709 vitamin E Substances 0.000 claims abstract description 4
- 150000003712 vitamin E derivatives Chemical class 0.000 claims abstract description 4
- 239000000463 material Substances 0.000 claims description 6
- 230000002441 reversible effect Effects 0.000 claims description 4
- 239000004255 Butylated hydroxyanisole Substances 0.000 claims description 3
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 claims description 3
- 229940043253 butylated hydroxyanisole Drugs 0.000 claims description 3
- 238000009472 formulation Methods 0.000 abstract 1
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 26
- 239000003205 fragrance Substances 0.000 description 22
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 14
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 13
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 13
- 150000001875 compounds Chemical class 0.000 description 13
- 208000010247 contact dermatitis Diseases 0.000 description 13
- 229930007744 linalool Natural products 0.000 description 13
- 239000013566 allergen Substances 0.000 description 12
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 10
- 206010070834 Sensitisation Diseases 0.000 description 9
- 230000001235 sensitizing effect Effects 0.000 description 8
- 201000004624 Dermatitis Diseases 0.000 description 7
- 206010070835 Skin sensitisation Diseases 0.000 description 7
- 229940087305 limonene Drugs 0.000 description 7
- 235000001510 limonene Nutrition 0.000 description 7
- 231100000370 skin sensitisation Toxicity 0.000 description 7
- XMGQYMWWDOXHJM-JTQLQIEISA-N (+)-α-limonene Chemical compound CC(=C)[C@@H]1CCC(C)=CC1 XMGQYMWWDOXHJM-JTQLQIEISA-N 0.000 description 6
- 239000005792 Geraniol Substances 0.000 description 6
- 229940113087 geraniol Drugs 0.000 description 6
- 150000003505 terpenes Chemical class 0.000 description 6
- 235000007586 terpenes Nutrition 0.000 description 6
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 5
- 208000010668 atopic eczema Diseases 0.000 description 5
- 230000003389 potentiating effect Effects 0.000 description 5
- 230000004913 activation Effects 0.000 description 4
- 230000002009 allergenic effect Effects 0.000 description 4
- 230000000172 allergic effect Effects 0.000 description 4
- 230000002500 effect on skin Effects 0.000 description 4
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 4
- UWKAYLJWKGQEPM-LBPRGKRZSA-N linalyl acetate Chemical compound CC(C)=CCC[C@](C)(C=C)OC(C)=O UWKAYLJWKGQEPM-LBPRGKRZSA-N 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 238000011002 quantification Methods 0.000 description 4
- 230000008313 sensitization Effects 0.000 description 4
- 231100000489 sensitizer Toxicity 0.000 description 4
- 231100000051 skin sensitiser Toxicity 0.000 description 4
- OOCCDEMITAIZTP-QPJJXVBHSA-N (E)-cinnamyl alcohol Chemical compound OC\C=C\C1=CC=CC=C1 OOCCDEMITAIZTP-QPJJXVBHSA-N 0.000 description 3
- 241000207199 Citrus Species 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 210000001744 T-lymphocyte Anatomy 0.000 description 3
- 229930003270 Vitamin B Natural products 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 235000020971 citrus fruits Nutrition 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 150000002432 hydroperoxides Chemical class 0.000 description 3
- 239000000543 intermediate Substances 0.000 description 3
- 235000019156 vitamin B Nutrition 0.000 description 3
- 239000011720 vitamin B Substances 0.000 description 3
- XMGQYMWWDOXHJM-SNVBAGLBSA-N (-)-α-limonene Chemical compound CC(=C)[C@H]1CCC(C)=CC1 XMGQYMWWDOXHJM-SNVBAGLBSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 2
- 235000019499 Citrus oil Nutrition 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 239000005770 Eugenol Substances 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- BJIOGJUNALELMI-ONEGZZNKSA-N Isoeugenol Natural products COC1=CC(\C=C\C)=CC=C1O BJIOGJUNALELMI-ONEGZZNKSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 2
- 208000030961 allergic reaction Diseases 0.000 description 2
- OOCCDEMITAIZTP-UHFFFAOYSA-N allylic benzylic alcohol Natural products OCC=CC1=CC=CC=C1 OOCCDEMITAIZTP-UHFFFAOYSA-N 0.000 description 2
- 238000006701 autoxidation reaction Methods 0.000 description 2
- BJIOGJUNALELMI-ARJAWSKDSA-N cis-isoeugenol Chemical compound COC1=CC(\C=C/C)=CC=C1O BJIOGJUNALELMI-ARJAWSKDSA-N 0.000 description 2
- QMVPMAAFGQKVCJ-UHFFFAOYSA-N citronellol Chemical compound OCCC(C)CCC=C(C)C QMVPMAAFGQKVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000010500 citrus oil Substances 0.000 description 2
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 2
- 229960002217 eugenol Drugs 0.000 description 2
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 2
- 210000004247 hand Anatomy 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 230000002045 lasting effect Effects 0.000 description 2
- UWKAYLJWKGQEPM-UHFFFAOYSA-N linalool acetate Natural products CC(C)=CCCC(C)(C=C)OC(C)=O UWKAYLJWKGQEPM-UHFFFAOYSA-N 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- BJIOGJUNALELMI-UHFFFAOYSA-N trans-isoeugenol Natural products COC1=CC(C=CC)=CC=C1O BJIOGJUNALELMI-UHFFFAOYSA-N 0.000 description 2
- 210000000707 wrist Anatomy 0.000 description 2
- CRDAMVZIKSXKFV-FBXUGWQNSA-N (2-cis,6-cis)-farnesol Chemical compound CC(C)=CCC\C(C)=C/CC\C(C)=C/CO CRDAMVZIKSXKFV-FBXUGWQNSA-N 0.000 description 1
- 239000000260 (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol Substances 0.000 description 1
- QMVPMAAFGQKVCJ-SNVBAGLBSA-N (R)-(+)-citronellol Natural products OCC[C@H](C)CCC=C(C)C QMVPMAAFGQKVCJ-SNVBAGLBSA-N 0.000 description 1
- WOAHJDHKFWSLKE-UHFFFAOYSA-N 1,2-benzoquinone Chemical compound O=C1C=CC=CC1=O WOAHJDHKFWSLKE-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-M 9-cis,12-cis-Octadecadienoate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC([O-])=O OYHQOLUKZRVURQ-HZJYTTRNSA-M 0.000 description 1
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- 108010078791 Carrier Proteins Proteins 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- 102000002004 Cytochrome P-450 Enzyme System Human genes 0.000 description 1
- 108010015742 Cytochrome P-450 Enzyme System Proteins 0.000 description 1
- 208000006313 Delayed Hypersensitivity Diseases 0.000 description 1
- 206010012434 Dermatitis allergic Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 241000134874 Geraniales Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 230000005867 T cell response Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000002386 air freshener Substances 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 125000000746 allylic group Chemical group 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- JGQFVRIQXUFPAH-UHFFFAOYSA-N beta-citronellol Natural products OCCC(C)CCCC(C)=C JGQFVRIQXUFPAH-UHFFFAOYSA-N 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000000484 citronellol Nutrition 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 229960000956 coumarin Drugs 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 150000002118 epoxides Chemical class 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000002979 fabric softener Substances 0.000 description 1
- 229940043259 farnesol Drugs 0.000 description 1
- 229930002886 farnesol Natural products 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000037189 immune system physiology Effects 0.000 description 1
- 230000002163 immunogen Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 238000010412 laundry washing Methods 0.000 description 1
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 description 1
- 229940049918 linoleate Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 239000012048 reactive intermediate Substances 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 231100000812 repeated exposure Toxicity 0.000 description 1
- 230000004043 responsiveness Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- CRDAMVZIKSXKFV-UHFFFAOYSA-N trans-Farnesol Natural products CC(C)=CCCC(C)=CCCC(C)=CCO CRDAMVZIKSXKFV-UHFFFAOYSA-N 0.000 description 1
- 230000005951 type IV hypersensitivity Effects 0.000 description 1
- 208000027930 type IV hypersensitivity disease Diseases 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Fats And Perfumes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
A method of reducing, avoiding or eliminating allergic contact dermatitis caused by the oxidation products of odorous chemical conventionally used in fragranced products and perfumes, comprising inhibiting oxidation of the odorous chemicals. Preferably, the oxidation is inhibited or reversed using an antioxidant selected from the group including vitamin E, vitamin E acetate, vitamin E linoleate, vitamin E esters, butylated hydroxytoluene (BHT) and butylated hydroxyanisole (BHA). The skin may be pre-/post-treated with the formulation before/after application of the fragranced product or perfume. A composition for reducing induction of contact allergy or reducing elicitation of allergic contact dermatitis of, in or on the skin in response to a fragranced product or perfume comprising an antioxidant agent is also provided.
Description
Methods and compounds for reducinR allergic reactions to fi-aaranced oroducts and perfumes The invention relates to compounds, compositions, fomiulations and methods for: avoiding; eliminating; or reducing ie inhibiting the induction and/or decreasing the severity and/or frequency of elicitation of allergic reactions to fragranced and perthme products.
As used herein fragrances are odorous compounds which are included as part of the composition of a variety products such as by way of example only cosmetics, toiletries, soap, deodorants, laundry washing products, laundry aids such as fabric conditioners, cleaning products, air fresheners and deodorising products.
As used herein perfumes are products which comprise one or more odorous chemical which are applied directly to the skin, hair or clothing of an individual or animal to enhance the general attractiveness of the wearer. A secondary role is to hide or mask malodours. The one or more odorous chemical is usually diluted with an organic solvent such as by way of example only ethyl alcohol.
As used herein a hapten is a low molecular weight chemical that is immunogenic only when attached to a carrier protein.
As used herein a prehapten is a chemical that itself is non-or low-sensitising but which may be transfonned into a hapten outside the skin by simple chemical transfonnation (such as air oxidation) without the requirement of a specific enzymatic system.
As used herein a prohapten is a chemical that itself is non-or low-sensitising but which may be transformed into a hapten in the skin by specific enzymatic systems.
The present invention aims to reduce, avoid or eliminate both the induction (sensitisation) of contact allergy and/or the elicitation of allergic contact dermatitis in individuals exposed to fragranced and perfUme products.
In a first aspect the invention relates to a method of reducing induction of contact allergy or reducing elicitation of allergic. contact dermatitis of, in or on the skin in rcsponse to a fragranced product or perfume by inhibiting oxidation of odorous chemicals.
in a second aspect the invention relates to a method wherein oxidation is inhibited or rcversed using an antioxidant.
In a further aspect the invention relates to a method wherein the antioxidant is selected from vitamin E, vitamin E acetate, vitamin E linoleate, vitamin E esters, butylated hydroxytoluene, butylated hydroxyanisole or like material.
In a further aspect the invention relates to a method wherein the skin is post-treated to inhibit or reverse oxidation after the application of the fragranced product or perfUme.
In a further aspect the invention relates to a method wherein the skin is pre-treated to inhibit or reverse oxidation before the application of the fragranced product or perfume.
In a further aspect the invention relates to a composition for reducing induction of contact allergy or reducing elicitation of allergic contact dermatitis of in or on the skin in response to a fragranced product or perfume comprising an antioxidant agent.
In a further aspect the invention relates to a composition wherein the antioxidant is selected from vitamin B, vitamin E acetate, vitamin B linoleate, vitamin B esters, butylated hydroxytoluene, butylated hydroxyanisole or like material.
in a further aspect the invention relates to a composition wherein by preventing oxidation, the time taken for the odorous chemicals to dissipate is increased.
Detailed Description:
Perfumes have been used in different cultures through the ages. Their main purpose is to enhance the general attractiveness of the wearer. A secondary role is to hide malodours.
There may be as many as 1000 different chemicals in a single fragrancc compound each of which plays a different role. The most volatile ("top notes"), with odours such as citrus, green-leafy and spicy give way to longer lasting heart' notes with floral odours.
The longest lasting (bottom notes') are often woody or musky in nature.
Current widely used perfumes often consist of a few highly concentrated odorous chemicals.
Many commercially used fragranced products and perifimes for application to or by consumers contain a mixture of organic odorous chemicals one or more of which may undergo chemical changes in or on the skin. Such changes may affect the odour of a chemical, and it may also change it from an innocuous form to a sensitising form which can have irritant properties which in turn give risk to allergic contact dermatitis.
An undesirable consequence of the generation of a number of chemically reactive intermediates is that these can combine with skin proteins rendcring them "foreign" and thus activating the immune system into the production of an allergic reaction ie a cell mediated, Type IV hypersensitivity.
Allergic Contact Dermatitis to fragranced products and perfumes takes the form of an inflammatory rash. Subjects can become sensitised to different odorous chemicals, which presents immunologically as an expansion of a population of T-lymphocytes which recognise and react to epicutaneous contact with the specific odorous chemical (or a chemical with close structural similarities) by producing inflammation within the skin.
Skin sensitization describes an immunological process whereby heightened responsiveness to a chemical allergen is induced. This process involves the chemical being presented to naïve T cells and a clone(s) of T cells being produced which will recognise the chemical in the periphery and induce a host inflammatory response to the chemical (elicitation reaction).
Normally an individual only becomes sensitised after one, or more usually, after several exposures to the fragranced or perfume product. Hence, products which are initially well tolerated may, after repeated usc, cause an allergic reaction.
Allergic contact dermatitis arises during the elicitation phase (clinical reaction in someone already sensitised or made allergic).
An active sensitisation phase (induction) is required before an allergic response can be elicited. Typically an individual only becomes sensitised to an allergenic chemical following repeated exposures. The number of exposures required for sensitisation to occur is highly variable, the frequency of use of the fragranced or perfume product may mean a period of many months or years precedes the acquisition of sensitisation. Many individuals will never become sensitised.
Classical fragrance dermatitis' occurs at sites where fragrances are often applied to the skin, such as on the hands, sides of the neck, behind the ears and on the wrists. However, fragrance dermatitis also occurs on other parts of the body such as the face, axillae and trunk.
Fragrance contact allergy is a clinically significant problem, being the second commonest cause of contact allergy after nickel, and gives rise to a significant degree of morbidity in the general population.
Many of the fragrance chemicals which give rise to allergic contact dermatitis have been well characterised, to the extent that diagnostically, 14 key materials are now present in two mixes, Fragrance Mix 1 (FM 1) and Fragrance Mix 2 (FM IT) used in routine investigations of possible allergic dermatitis. Johansen, J.D., Lepoittevin, i-P., Baskcttcr, D., McFadden, J. and Sosted, H. (2006) Allergens of special interest. Contact Dermatitis, 4th edition, Eds Frosch PJ, Menné T and Lepoiftevin J-P. Springer, Berlin, pp 507 536.
Of these 14, only a minority arc considered to be directly reactive chemicals (the classical haptcns of allergic contact dermatitis). At least half of them require an oxidative process to produce a sensitizing species -these are commonly referred to as prohaptens Dupuis, G. and Benezra, C. (1982) Contact Dermatitis to Simple Chemicals: A Molecular Approach. New York: Marcel Dekker.
By way of example only cinnamyl alcohol, eugenol, isoeugenol, geraniol, farnesol, citronellol, and coumarin are important prohaptens which undergo oxidation to form sensitizing intermediate forms which have a role in the generation of allergic contact dermatitis Basketter DA (1992) Skin sensitization to cinnamic alcohol: The role of skin metabolism. Acta Derm Vencreol. 72: 264 -265; and Barratt MD and Basketter DA (1992) Possible origin of the sensitization potential of isoeugenol and related compounds.
Preliminary studies of potential reaction mechanisms. Contact Dermatitis 27: 98-104; and Bertrand F, Basketter DA, Roberts DW and Lepoiftevin J-P (1997) Skin sensitization to eugenol and isocugenol in mice: Evidence of different metabolic pathways involving orthoquinone and quinonemethide intermediates. Chem Res Toxicol, 10: 335 -343; and Smith CK and Hotchkiss SAM (2002) Allergic Contact Dcmatitis: Chemical and Metabolic Mechanisms. Taylor and Francis, London; and Hagvall L, Bäcktorp C, Svensson 5, Nyman G, Börje A, Karlberg AT. (2007) Fraancc compound geraniol forms contact allergens on air exposure. Identification and quantification of oxidation products and effect on skin sensitization. Chem Res Toxicol. 20: 807 -814.
in addition to the components of FM I and FM Ii, other notable fragrance materials such as limonene and linalool also require oxidation to render them allergenic, Karlberg A-T, Basketter DA, Goosscns A and Lepoittevin i-p (1999) Regulatory classification of substances oxidized to skin sensitizers by exposure to the air. Contact Dermatitis 40: 183 -188; and Christensson JB, Matura M, Gruvberger B, Bruze M, Karlberg AT (2010) Linalool--a significant contact sensitizer after air exposure. Contact Dermatitis 62: 32 -41.
To date, the details of the processes by which innocuous fragrance compounds arc converted to sensitizing intermediates have not been ftilly defined. However, for at least some important prehaptens, cg limonene and linalool, it is clear that air oxidation is the critical factor Karlberg A-T, Basketter DA, Goossens A and Lepoittevin i-P (1999) Regulatory classification of substances oxidized to skin sensitizers by exposure to the air.
Contact Dermatitis 40: 183 -188; and Matura M, Skold M, Börje A, Andersen KE. Bruze M, Frosch P. Goossens A, Johansen SD, Svedman C, White IR, Karlbcrg AT. (2005) Selected oxidized fragrance terpenes are common contact allergens. Contact Dermatitis 52: 320-328.
For others, the detail of the oxidative process(cs) remains the subject of investigation, eg cugcnol and isoeugcnol Sieben S. Hertl M, Al Masaoudi T, MerkHF, Blömckc B. (2001) Characterization of T cell responses to fragrances. Toxicol AppI Pharmacol. 172: 172 -178.
Prehaptcn activation as a result of air or auto oxidation is known to be responsible for the generation of hydroperoxides which are some of the most prominent sensitizing agents involved in contact allergy.
Prehaptcn activation (in contrast to bioactivation of prohaptens) can be reduced by measures adopted in the handling and storage of perfumes for example: perfume compounds may be stored under anaerobic condition (eg tinder nitrogen; and an antioxidant may he added (eg BHT)to reduce oxidation. Similarly fragraneed products and perfumes are generally stored in cool dark conditions so as to minimize oxidation. However all theres measures arc only to preserve the integrity of the perfUme compounds dunng storage, The fragrance substances that have been investigated so far are all terpenes with oxidizable allylic positions that arc able to form sensitising hydroperoxides as primary oxidation products upon air exposure. The primary oxidation products form secondary oxidation products some of which are allergenic Karlberg et al. Chem Res Toxicol 2008: 21:53-69.
Most terpenes oxidize on air exposure due to their inherent properties. Depending on the stability of the formed oxidation products a difference in the sensitization potency of the oxidized terpenes can be seen. Oxidation products of commonly used fragrance terpenes (limonene, linalool, geraniol, linalyl acetate) have been identified as potent sensitisers in predictive animal tests. Karlberg A-I, Boman A, Melin B. Animal experiments on the allergcnicity of d-limonene -the citrus solvent. Ann Occup Hyg 1991: 35:419-426; and Karlbcrg A-I, Magnusson K, Nilsson U. Air oxidation of d-limonene -the citrus solvent -creates potent allergens. Contact Dermatitis 1992: 26: 332-340; and Karlberg A-T, Shao LP, Nilsson U, Gafvert E, Nilsson JLG. Hydroperoxides in oxidized d-limonene identified as potent contact allergens. Arch Derm Res 1994: 286: 97-103; and Skold M, Borje A, Matura M, Karlberg A-T. Studies on the autoxidation and sensitizing capacity of the fragrance chemical linalool, identifying a linalool hydroperoxide. Contact Dermatitis 2002: 46: 267-272; and Sköld M, Börje A, Harambasic E. Karlberg A-T. Contact allergens formed on air exposure of linalool. Identification and quantification of primary and secondary products and the effect on skin sensitization. Chem Res Toxicol 2004: 17: 1697-1705; and Hagvall L, Bäcktorp C, Svensson S. Nyman G. Börje A, Karlberg A-T.
The fragrance compound geraniol forms contact allergens on air exposure. Identification and quantification of oxidation products and effect on skin sensitization. Chem Res Toxicol 2007: 20: 807-814; and Sköld M, Hagvall L, Karlbcrg A-T. Autoxidation of linalyl acetate, the main component of lavender oil, creates potent contact allergens.
Contact Dermatitis 2008: 58: 9-14.
The oxidized fragrance tcrpcnes limonene and linalool have been tested in consecutive dermatitis patients and found to give frequent contact allergic reactions Karlbcrg A-I, Dooms-Goossens A. Contact allergy to oxidized d-limoncne among dermatitis patients.
Contact Dermatitis 1997: 36: 20 1-206; and Matura M, Goossens A, Bordalo 0, Garcia-Bravo B, Magnusson K, Wrangsjö K, Karlberg A-I. Oxidized citrus oil (R-Iimonene) -A frequent skin sensitizer in Europe. J Am Acad Derm 2002: 47: 709-714; and Matura M, Goossens A, Bordalo 0, Garcia-Bravo B, Magnusson K, Wrangsjö K, Karlberg A-I.
Patch testing with oxidized limonene and its hydroperoxide fraction. Contact Dermatitis 2003: 49: 15-21; and Matura M, Skold M, Börje A, Andersen ICE, Bruze M, Frosch F, Goossens A, Johanscn JD, Svcdman C, White IR, Karlberg A-T. Selected oxidized fragrance terpenes are common contact allergens. Contact Dermatitis 2005: 52: 320-328; and Matura M, Skold M, Börje A, Andersen KE, Bruze M, Frosch F, Goossens A, Johansen JD, Svedman C, White JR. Karlberg A-I. Not only oxidized R-(+)-, but also S- (-)-limonene is a common cause of contact allergy in dermatitis patients in Europe.
Contact Dermatitis: 2006: 55: 274-279; and Bràred-Christensson J, Matura M, Gi-uvberger B, Bruze M, Karlberg A-I. Linalool -a significant contact sensitizer after air exposure. Contact Dermtitis 2010: 62: 32-41.
Non-oxidized limonene and linalool do not (or very rarely) cause allergic reactions.
Santucci B et al. Contact Dermatitis 1987: 16: 93-95 (limonene 2%: 0/1200 pos); and Fregert Set aL Contact Dermatitis Newsletter 1969: 5: 85-86. (linalool 10%: 4/792pos (0.5%); and Frosch FJ et al. Contact Dermatitis 1995: 33: 333-342 (linalool 5% and 1%: 0/100 pos).
Due to the complexity of scented products, which are mixtures of many different fragrance substances, there is no published data on the presence of oxidation products in these consumer products. However numerous clinical studies show a clear connection between contact allergy to oxidized limoncne and linalool and contact allergy to other fragrance markers Karlberg A-I, Doonts-Goossens A. Contact allergy to oxidized d-lirnonene among dermatitis patients. Contact Dermatitis 1997: 36: 201-206; and Matura M, Goossens A, Bordalo 0, Garcia-Bravo B, Magnusson K, Wrangsjö K, Karlberg A-I.
Oxidized citrus oil (R-limoncne) -A frequent skin sensitizer in Europe. J Am Acad Dcnn 2002: 47: 709-714; and Matura M, Sköld M, Börjc A, Andersen KE, Bruze M, Frosch P, Goossens A, Johansen JD, Svedman C, White IR, Karlberg A-T. Sclccted oxidized fragrance terpenes are common contact allergens. Contact Dermatitis 2005: 52: 320-328; and Matura M, Sköld M, Börje A, Andersen KE, Bruze M, Frosch P, Goossens A, Johansen JD, Svedman C, White IR, Karlberg A-T. Not only oxidized R-(+)-, but also S-(-)-limonene is a common cause of contact allergy in dermatitis patients in Europe.
Contact Dermatitis: 2006: 55: 274-279; and Brâred-Christensson J, Matura M, Gruvberger B, Bruze M, Karlberg A-T. Linalool -a significant contact sensitizer after air exposure. Contact Dermtitis 2010: 62: 32-4 1.
Other important allergenic products such as aldchydes and epoxides are also produced as a result of both oxidation and bioactivation routcs depending on the structure of the compound.
It is not always possible to know whether a particular allergen that is not directly reactive acts as a prehapten or as a prohapten or both because the oxidation and bioactivation product can often give the same compound for example geraniol.
Geraniol has been thoroughly studied and found to act as both a prehapten and a prohapten and forms the aldehyde geranial, epoxy-geraniol, and also epoxy-geranial via both activation routes (oxidation and bioactivation) Hagvall L, Bãcktorp C, Svensson S, Nyman G. Börje A, Karlberg A-T. The fragranc compound geraniol forms contact allergens on air exposure. Identification and quantification of oxidation products and effect on skin sensitization. Chem Res Toxicol 2007: 20: 807-814; and Hagvall L, Baron JM, BOrje A, WeidolfL, Merk HF, Karlberg A-T. Cytochrome P450 mediated activation of the fragrance compound geraniol forms potent contact allergens. Toxicol AppI Pharmacol 2008: 233: 308-313.
As with geraniol, when haptens are formed from compounds which act as both prohaptens and prehaptens, the impact on the sensitization potency is thought to be higher when an individual is exposed to the oxidized compound compared to thc sensitization potency caused by bioactivation.
This effect is likely the result of dosage differences, oxidation giving rise to higher hapten concentrations than bioactivation.
Thus it appcars that oxidation either autooxidation; by the air; or as a result of a specific enzymatic systems in the skin is crucial in converting a range of otherwise innocuous fragrance compounds into sensitizing forms likely to give rise to contact dermatitis.
The present invention relies on this realization and provides methods, and compositions for reducing or eliminating the allergenicity of odorous chemicals by inhibiting, reducing or reversing oxidation.
The present invention provides compositions which contain one or more anti-oxidising agent.
The compositions of the present invention prevent oxidation of odorous chemicals thereby reducing the risk of allergic sensitisation to the fragranced or perfume product.
Preferably the compositions of the present invention have the added benefit of prolonging the pleasant odour by preventing oxidation of odorous chemicals.
Optionally, the compositions for inhibiting oxidation are applied to the skin before or after the application of the fragranced or perfume product in a pre-treatment and/or post treatment step.
Preferably the compositions for inhibiting oxidation are applied only to areas where the allergic reactions are most pronounced, such as on the hands, sides of the neck, behind the cars and on the wrists.
Claims (1)
- <claim-text>Claims: I. A method of reducing induction of contact allergy or reducing elicitation of allergic contact dermatitis of, in or on the skin in response to a fragranced product or perftime by inhibiting oxidation of odorous chemicals.</claim-text> <claim-text>2. A method as claimed in claim 1 whcrein oxidation is inhibitcd or reversed using an antioxidant.</claim-text> <claim-text>3. A method as claimed in claim 2 whcrein the antioxidant is selected from vitamin E, vitamin E acetate, vitamin E linoleate, vitamin E esters, butylated hydroxytoluene, butylated hydroxyanisole or like material.</claim-text> <claim-text>4. A method as claimed in any preceding claim wherein the skin is post-treated to inhibit or reverse oxidation after the application of the fragranced product or perfume.</claim-text> <claim-text>5. A method as claimed in any preceding claim wherein the skin is pre-treated to inhibit or reverse oxidation before the application of the fragranced product or perfume.</claim-text> <claim-text>6. A composition for reducing induction of contact allergy or reducing elicitation of allergic contact dermatitis of, in or on the skin in response to a fragranccd product or perfume comprising an antioxidant agent.</claim-text> <claim-text>7. A composition as claimed in claim 6 wherein the antioxidant is selected from vitamin E, vitamin E acetate, vitamin E linoleate, vitamin E esters, butylated hydroxytolucnc, butylated hydroxyanisolc or like material.</claim-text> <claim-text>8. A composition as claimed in claims 6 to 7 wherein by preventing oxidation, the time taken for the odorous chemicals to dissipate is increased.</claim-text> <claim-text>9. A composition or method substantially as hereinbefore described.</claim-text>
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1114692.5A GB2493955A (en) | 2011-08-25 | 2011-08-25 | Methods and compositions for reducing allergic reactions to fragranced products and perfumes |
PCT/EP2012/065954 WO2013026755A1 (en) | 2011-08-25 | 2012-08-15 | Methods and compounds for reducing allergic reactions to fragranced products and perfumes |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1114692.5A GB2493955A (en) | 2011-08-25 | 2011-08-25 | Methods and compositions for reducing allergic reactions to fragranced products and perfumes |
Publications (2)
Publication Number | Publication Date |
---|---|
GB201114692D0 GB201114692D0 (en) | 2011-10-12 |
GB2493955A true GB2493955A (en) | 2013-02-27 |
Family
ID=44838700
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB1114692.5A Withdrawn GB2493955A (en) | 2011-08-25 | 2011-08-25 | Methods and compositions for reducing allergic reactions to fragranced products and perfumes |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB2493955A (en) |
WO (1) | WO2013026755A1 (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4443685A1 (en) * | 1994-12-08 | 1996-06-13 | Henkel Kgaa | Use of tocopherols as stabilizers for fragrances, perfume oils and perfumes |
EP1342473A1 (en) * | 1996-05-31 | 2003-09-10 | BIO.LO.GA. S.r.l. | Esters of vitamin E as products for topical application |
WO2008038807A1 (en) * | 2006-09-29 | 2008-04-03 | Kobayashi Pharmaceutical Co., Ltd. | External composition for skin |
US20090258841A1 (en) * | 2008-04-01 | 2009-10-15 | Michael Patrick Murphy | Compositions and methods for skin care |
GB2471135A (en) * | 2009-06-19 | 2010-12-22 | H D S Ltd | Hair dye composition and use in reducing contact allergy |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3826889A1 (en) * | 1988-08-08 | 1990-02-15 | Otto Fucks Gmbh & Co Kg H | Petrolatum-based cosmetic composition with an anti-metal-allergy action |
-
2011
- 2011-08-25 GB GB1114692.5A patent/GB2493955A/en not_active Withdrawn
-
2012
- 2012-08-15 WO PCT/EP2012/065954 patent/WO2013026755A1/en active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4443685A1 (en) * | 1994-12-08 | 1996-06-13 | Henkel Kgaa | Use of tocopherols as stabilizers for fragrances, perfume oils and perfumes |
EP1342473A1 (en) * | 1996-05-31 | 2003-09-10 | BIO.LO.GA. S.r.l. | Esters of vitamin E as products for topical application |
WO2008038807A1 (en) * | 2006-09-29 | 2008-04-03 | Kobayashi Pharmaceutical Co., Ltd. | External composition for skin |
US20090258841A1 (en) * | 2008-04-01 | 2009-10-15 | Michael Patrick Murphy | Compositions and methods for skin care |
GB2471135A (en) * | 2009-06-19 | 2010-12-22 | H D S Ltd | Hair dye composition and use in reducing contact allergy |
Non-Patent Citations (3)
Title |
---|
British Journal of Dermatology, vol 146, 2002, pages 649-656 * |
Chemical Research in Toxicology, vol. 21, No. 1, 2008, pages 53-69 * |
Chemical Research in Toxicology, vol. 21, No. 8, 2008, pages 1536-1547 * |
Also Published As
Publication number | Publication date |
---|---|
GB201114692D0 (en) | 2011-10-12 |
WO2013026755A1 (en) | 2013-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kanlayavattanakul et al. | Body malodours and their topical treatment agents | |
EP2771071B1 (en) | Perfuming compositions and uses thereof | |
JP5911480B2 (en) | Perfume compositions and their use | |
US9428712B2 (en) | Perfuming compositions and uses thereof | |
JP2004262900A (en) | Body odor-suppressing perfume composition | |
EP3595732B1 (en) | Use of a composition containing 1,8-para-menthenethiol and 3-mercaptohexyl acetate as an odour-masking agent | |
JP6427113B2 (en) | Fragrance composition | |
Mahajan | Perfumes and associated allergens: A brief review | |
Gimenez‐Arnau et al. | Principles and methodology for identification of fragrance allergens in consumer products | |
GB2493955A (en) | Methods and compositions for reducing allergic reactions to fragranced products and perfumes | |
CN104046513A (en) | Novel decenal mixture and application in perfume composition | |
Alemdar et al. | Systematically investigation on the spectral, antioxidant and antibacterial properties of fragrant methyl benzoate esters containing electron withdrawing and electron releasing groups | |
EP4355436A1 (en) | 1,3-butylene glycol compositions and methods of use thereof | |
JP5616615B2 (en) | Deodorant cosmetic | |
WO2022125478A1 (en) | Antioxidant compositions | |
JP2001097839A (en) | Fiber for controlling smell of aged person and agent for treating fiber | |
CN112791015A (en) | Essence solubilizer and preparation method thereof | |
Athar | Detrimental effects of perfumes, aroma and cosmetics | |
FR2915387A1 (en) | Perfumed and/or perfuming cosmetic composition, comprises odoriferous molecule and/or its mixture, and film forming agent of plant origin soluble in hydroalcoholic medium, in hydroalcoholic solvent medium | |
KR102599099B1 (en) | Fragrance composition for masking body odor and cosmetic composition containing the same | |
JP5350656B2 (en) | Antioxidant or active oxygen scavenger, and perfume composition and cosmetics containing the same | |
Gajić et al. | Influence of Air on Essential Oil Constituents | |
KR102460455B1 (en) | Perfume composition for expressing the fragrance of Leucocoryne hybrida | |
US7576045B2 (en) | Use of vinic alcohol in personal care products, cosmetics and perfumes | |
Funesti | Perfumery applications: Functional products |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |